Production Equipment
Compresses prepared powder or granules into tablets with a specified shape, size, and output range.
Selection starting point
Model index
The YOKO-GY-D rotary tablet press is intended for pharmaceutical tablets and nutraceutical tablets. Selection is reviewed against prepared powder and granules, target output, utilities, and line interfaces. Final configuration is defined in the quotation and technical agreement.
The YOKO-Y-D rotary tablet press is intended for pharmaceutical tablets and nutraceutical tablets. Selection is reviewed against prepared powder and granules, target output, utilities, and line interfaces. Final configuration is defined in the quotation and technical agreement.
The YOKO-Y-B rotary tablet press is intended for pharmaceutical tablets and nutraceutical tablets. Selection is reviewed against prepared powder and granules, target output, utilities, and line interfaces. Final configuration is defined in the quotation and technical agreement.
The YOKO-DY-D single-punch tablet press is intended for pharmaceutical tablets and nutraceutical tablets. Selection is reviewed against prepared powder and granules, target output, utilities, and line interfaces. Final configuration is defined in the quotation and technical agreement.
YOKO-GY-B is a high-output rotary tablet-press family with ten reference configurations. The catalogue covers 29 to 75 punch stations, maximum main pressure references of 80 or 100 kN, and nominal capacities from 139,200 to 675,000 tablets per hour, with one lower-output range also listed. The correct model depends on tablet geometry, tooling, formulation compressibility, dwell time, containment, and realistic downstream capacity.
The YOKO-HY-D single-punch tablet press is intended for pharmaceutical tablets and nutraceutical tablets. Selection is reviewed against prepared powder and granules, target output, utilities, and line interfaces. Final configuration is defined in the quotation and technical agreement.
The YOKO-DY-E single-punch tablet press is intended for pharmaceutical tablets and nutraceutical tablets. Selection is reviewed against prepared powder and granules, target output, utilities, and line interfaces. Final configuration is defined in the quotation and technical agreement.